Pravastatin in heterozygous familial hypercholesterolemia: Low-density lipoprotein (LDL) cholesterol-lowering effect and LDL receptor activity on skin fibroblasts

This publication has 21 references indexed in Scilit:

• Pravastatin vs gemfibrozil in the treatment of primary hypercholesterolemia. The Italian Multicenter Pravastatin Study I
  Archives of internal medicine (1960), 1991
• Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: Lack of effect on low-density lipoprotein concentrations or turnover
  The Journal of Pediatrics, 1988
• HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
  New England Journal of Medicine, 1988
• Lowering cholesterol, 1988. Rationale, mechanisms, and means.
  Journal of Clinical Investigation, 1988
• CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
• A Receptor-Mediated Pathway for Cholesterol Homeostasis
  Science, 1986
• Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.
  Journal of Clinical Investigation, 1984
• The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
  JAMA, 1984
• Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activity
  FEBS Letters, 1976
• Immunochemical quantitation of antigens by single radial immunodiffusion
  Immunochemistry, 1965